Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jul 1, 2010


Fred Walder has joined Fluidigm as chief business officer. He was most recently senior vice president of customer and commercial excellence at Thermo Fisher Scientific.

Walder began his career as an engineering and scientific associate at Sandia National Laboratories and then moved to Nicolet Instrument Corporation where he held a variety of technical and management positions.

WaferGen Biosystems has added two new members to its scientific advisory board: Andre Marion, co-founder and former chairman and CEO of Applied Biosystems (now part of Life Technologies); and Muneesh Tewari, a faculty member at Fred Hutchinson Cancer Research Center.

Marion was chairman, CEO, and president of Applied Biosystems when it merged with Perkin-Elmer in 1993. He retired in 1995.

Tewari's work is focused on studying the role of microRNAs in cancer, as well as on developing microRNA-based biomarker approaches for oncology.

NanoString Technologies has appointed Brad Gray as president and chief executive officer and Nalini Murdter as chief business officer.

Gray joins the company from Genzyme Genetics, where he was most recently vice president of product and business development. Prior to Genzyme, Gray was a management consultant in the healthcare practice of McKinsey & Company.

Murdter most recently worked at Agilent Technologies as global product marketing manager in the company's Life Sciences and Chemical Analysis division. Prior to Agilent, Nalini was director of product and business development at Adeza Biomedical (later acquired by Cytyc/Hologic).

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.